Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Clinical Pharmacology and Therapeutics|April 12, 2023
Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adultsMarlon Liyanage, Chelsea L Blaquera, Joseph Piscitelli, et al.
Scientific Reports|November 6, 2019
Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney DiseaseAlexander J Prokopienko, Raymond E West, Daniel P Schrum, et al.
Contemporary Clinical Trials|July 17, 2024
Underrepresentation of black individuals in pivotal trials for novel anticancer drugs: Potential consequence of using estimated creatinine clearance to assess kidney function?Morgan A Butrovich, Allison C Reaves, Jamie Heyward, et al.
Msphere|September 26, 2023
Clinical rel mutations in Staphylococcus aureus prime pathogen expansion under nutrient stressEdwin Chen, Marla G Shaffer, Robert E Bilodeau, et al.
Clinical Pharmacology and Therapeutics|October 10, 2017
Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATPMing-Liang Tan, Kenta Yoshida, Ping Zhao, et al.
European Journal of Pharmacology|March 5, 2013
The anti-oxidant effects are not the main mechanism for glutamine's protective effects on acute kidney injury in miceZhi-Yong Peng, Feihu Zhou, Hong-Zhi Wang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 19, 2015
Extracorporeal Treatment in Phenytoin Poisoning: Systematic Review and Recommendations from the EXTRIP (Extracorporeal Treatments in Poisoning) WorkgroupKurt Anseeuw, James B Mowry, Emmanuel A Burdmann, et al.
Journal of Clinical Pharmacology|November 18, 2021
Pharmacokinetics and Concentration-Response of Dupilumab in Patients With Seasonal Allergic RhinitisMohamed A Kamal, Yoko Franchetti, Ching-Ha Lai, et al.
Kidney Medicine|May 7, 2025
Effect of a Population Health Management Intervention on Medication Therapy Problems in People With Chronic Kidney Disease: Post Hoc Analysis of the K-CHAMP Cluster-Randomized TrialMelanie R Weltman, Zhuoheng Han, Linda-Marie U Lavenburg, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2023
Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development: Landscape Analysis of Anticancer Agents Approved from 2015 to 2019Morgan A Butrovich, Allison C Reaves, Jamie Heyward, et al.
Pageof 15